Sichuan Baili Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Sichuan Baili Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 9 active records with this name as holder; 17 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
54 acceptance records as first applicant, grouped into 29 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
注射用BL-M11D1 · No verified English name 1 records · Latest accepted 2026/10/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600326 | Supplement | 2026/10/29 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
SI-B001双特异性抗体注射液 · No verified English name 12 records · Latest accepted 2026/10/13
Supplement · 3New drug · 9
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600302 | Supplement | 2026/10/13 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| CXSB2400051 | Supplement | 2024/05/29 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| CXSL2400182 | New drug | 2024/03/14 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| CXSB2300035 | Supplement | 2023/04/15 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| CXSL2101511 | New drug | 2021/12/27 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101461 | New drug | 2021/12/06 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101233 | New drug | 2021/08/03 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101232 | New drug | 2021/08/03 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101085 | New drug | 2021/05/20 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101086 | New drug | 2021/05/19 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101083 | New drug | 2021/05/19 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101084 | New drug | 2021/05/18 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
注射用BL-M05D1 · No verified English name 1 records · Latest accepted 2026/08/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600216 | Supplement | 2026/08/18 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
注射用BL-M07D1 · No verified English name 1 records · Latest accepted 2026/07/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600136 | Supplement | 2026/07/02 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
镥[177Lu]-BL-ARC001注射液 · No verified English name 1 records · Latest accepted 2026/06/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600116 | Supplement | 2026/06/22 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
注射用BL-M14D1 · No verified English name 2 records · Latest accepted 2026/06/11
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600110 | Supplement | 2026/06/11 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| CXSB2600042 | Supplement | 2026/03/02 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 2 records · Latest accepted 2026/03/21
Generic · 2
Enalapril Maleate Oral Solution 2 records · Latest accepted 2026/01/05
Supplement · 1Generic · 1
注射用BL-B16D1 · No verified English name 1 records · Latest accepted 2025/09/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2500177 | Supplement | 2025/09/23 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
Methotrexate Injection 1 records · Latest accepted 2025/04/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501497 | Generic | 2025/04/19 | Sichuan Baili Pharmaceutical Co., Ltd.; Guizhou Fu Kang Ren Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Raltitrexed for Injection 1 records · Latest accepted 2025/01/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500415 | Generic | 2025/01/22 | Sichuan Baili Pharmaceutical Co., Ltd.; Guizhou Fu Kang Ren Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Levofolinate Calcium for Injection 2 records · Latest accepted 2025/01/15
Supplement · 1Generic · 1
Azithromycin For Injection 1 records · Latest accepted 2024/08/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450445 | Supplement | 2024/08/27 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
Guanfacine Hydrochloride Extended Release Tablets 4 records · Latest accepted 2024/02/03
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400473 | Generic | 2024/02/03 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2400472 | Generic | 2024/02/03 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2102139 | Generic | 2021/12/06 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2102138 | Generic | 2021/12/06 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
Gemcitabine Hydrochloride for Injection 1 records · Latest accepted 2023/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303364 | Generic | 2023/12/06 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
Cytarabine for Injection 1 records · Latest accepted 2023/11/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303254 | Generic | 2023/11/25 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
Carboplatin Injection 1 records · Latest accepted 2023/09/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302625 | Generic | 2023/09/29 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
Pemetrexed Disodium for Injection 1 records · Latest accepted 2023/09/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302563 | Generic | 2023/09/22 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
注射用BL-B01D1 · No verified English name 2 records · Latest accepted 2023/05/10
Supplement · 1New drug · 1
Nicorandil for Injection 1 records · Latest accepted 2023/03/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300776 | Generic | 2023/03/14 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
他达拉非口腔速溶膜 · No verified English name 2 records · Latest accepted 2023/03/10
New drug · 2
Azithromycin for Suspension 1 records · Latest accepted 2023/02/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300634 | Generic | 2023/02/24 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
卡托普利口服溶液 · No verified English name 2 records · Latest accepted 2022/08/23
New drug · 2
盐酸多奈哌齐口腔速溶膜 · No verified English name 2 records · Latest accepted 2022/05/11
New drug · 2
注射用BL-M02D1 · No verified English name 1 records · Latest accepted 2022/02/08
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200075 | New drug | 2022/02/08 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
SI-B003双特异性抗体注射液 · No verified English name 3 records · Latest accepted 2021/12/28
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2101510 | New drug | 2021/12/28 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101452 | New drug | 2021/11/26 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| CXSL2101451 | New drug | 2021/11/26 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
吸入用七氟烷 · No verified English name 2 records · Latest accepted 2021/08/27
Generic · 2
氨金黄敏颗粒 · No verified English name 1 records · Latest accepted 2021/08/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101704 | Supplement | 2021/08/20 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
GNC-035四特异性抗体注射液 · No verified English name 1 records · Latest accepted 2021/04/27
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2101045 | New drug | 2021/04/27 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 2 applicationsNo longer listed under review: 2 applications
- 2026/11/14No longer listed under review
Raltitrexed for Injection
CYHS2500415
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/01/22
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/12No longer listed under review
注射用BL-M05D1 · No verified English name
CXSB2600216
Fact date: 2026/11/12 · Date added to this site: 2026/11/12
Accepted: 2026/08/18
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/29Accepted
注射用BL-M11D1 · No verified English name
CXSB2600326
Fact date: 2026/10/29 · Date added to this site: 2026/10/30
View source ↗ - 2026/10/13Accepted
SI-B001双特异性抗体注射液 · No verified English name
CXSB2600302
Fact date: 2026/10/13 · Date added to this site: 2026/10/22
View source ↗
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 注射用BL-M11D1 · No verified English name | CXSB2600326 | Supplement | 2026/10/29 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| SI-B001双特异性抗体注射液 · No verified English name | CXSB2600302 | Supplement | 2026/10/13 | Sichuan Baili Pharmaceutical Co., Ltd.; Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2600691 | Generic | 2026/03/21 | Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| Methotrexate Injection | CYHS2501497 | Generic | 2025/04/19 | Sichuan Baili Pharmaceutical Co., Ltd.; Guizhou Fu Kang Ren Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
9 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Guanfacine Hydrochloride Extended Release Tablets | Sichuan Baili Pharmaceutical Co., Ltd. | Sichuan Baili Pharmaceutical Co., Ltd. | 国药准字H20253442 | 2025/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | 国药准字H20253258 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pemetrexed Disodium for Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | 国药准字H20253303 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carboplatin Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | 国药准字H20249713 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cytarabine for Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized | 国药准字H20249109 | 2024/10/22 | Not stated by source | CDE ↗ |
| Nicorandil for Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Sichuan Baili Pharmaceutical Co., Ltd. | 国药准字H20244980 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin for Suspension | Sichuan Baili Pharmaceutical Co., Ltd. | Sichuan Baili Pharmaceutical Co., Ltd. | 国药准字H20244232 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cisatracurium Besylate Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Sichuan Baili Pharmaceutical Co., Ltd. | 国药准字H20223009 | 2022/01/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cisatracurium Besylate Injection | Sichuan Baili Pharmaceutical Co., Ltd. | Sichuan Baili Pharmaceutical Co., Ltd. | 国药准字H20223008 | 2022/01/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
17 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 甘草酸二铵 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190008153 | A | 2026/01/09 | CDE ↗ |
| 盐酸伐昔洛韦 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190008151 | A | 2026/01/29 | CDE ↗ |
| 恩曲他滨 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190006719 | A | 2023/03/24 | CDE ↗ |
| 富马酸替诺福韦二吡呋酯 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190006668 | A | 2023/03/24 | CDE ↗ |
| 盐酸右美托咪定 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190006458 | A | 2026/04/16 | CDE ↗ |
| 甲磺酸左氧氟沙星 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190005950 | A | 2026/01/09 | CDE ↗ |
| 加替沙星 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190002633 | A | 2025/10/30 | CDE ↗ |
| 利福昔明 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190002626 | A | 2025/10/30 | CDE ↗ |
| 消旋卡多曲 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190002614 | A | 2025/10/30 | CDE ↗ |
| 盐酸尼非卡兰 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20190001389 | A | 2024/08/03 | CDE ↗ |
| 甘氨酰酪氨酸 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170001454 | I | — | CDE ↗ |
| 阿达帕林 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170001351 | A | 2023/03/24 | CDE ↗ |
| 过氧苯甲酰 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170001350 | A | 2023/03/24 | CDE ↗ |
| 奥美沙坦酯 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170001268 | A | 2023/03/24 | CDE ↗ |
| 盐酸多奈哌齐 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170001178 | I | — | CDE ↗ |
| 利奈唑胺 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170001152 | I | — | CDE ↗ |
| 硝酸异康唑 · No verified English name | Sichuan Baili Pharmaceutical Co., Ltd. | Y20170000320 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
75 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| SI-B001双特异性抗体注射液 · No verified English name | CXSL2601110 | New drug | 2026/10/13 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2601109 | New drug | 2026/10/13 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| SI-B037双特异性抗体注射液 · No verified English name | CXSL2601077 | New drug | 2026/09/30 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M08D1 · No verified English name | CXSL2600932 | New drug | 2026/08/31 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 镥[177Lu]-BL-ARC001注射液 · No verified English name | CXSL2600804 | New drug | 2026/07/31 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| SI-B001双特异性抗体注射液 · No verified English name | CXSL2600802 | New drug | 2026/07/31 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600781 | New drug | 2026/07/28 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M12D1 · No verified English name | CXSL2600763 | New drug | 2026/07/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M09D1 · No verified English name | CXSL2600676 | New drug | 2026/06/25 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1(皮下注射) · No verified English name | CXSL2600565 | New drug | 2026/05/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600453 | New drug | 2026/04/29 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600428 | New drug | 2026/04/21 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M14D1 · No verified English name | CXSL2600361 | New drug | 2026/03/30 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M08D1 · No verified English name | CXSL2600348 | New drug | 2026/03/24 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600279 | New drug | 2026/02/28 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| SI-B036双特异性抗体注射液 · No verified English name | CXSL2600271 | New drug | 2026/02/28 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600123 | New drug | 2026/01/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600122 | New drug | 2026/01/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600091 | New drug | 2026/01/16 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2600072 | New drug | 2026/01/13 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| BL-ARC002注射液 · No verified English name | CXSL2600019 | New drug | 2026/01/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501115 | New drug | 2025/12/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501114 | New drug | 2025/12/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501113 | New drug | 2025/12/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501112 | New drug | 2025/12/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501111 | New drug | 2025/12/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501105 | New drug | 2025/12/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501104 | New drug | 2025/12/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501102 | New drug | 2025/12/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2501101 | New drug | 2025/12/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M11D1 · No verified English name | CXSL2501099 | New drug | 2025/12/19 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M24D1 · No verified English name | CXSL2500680 | New drug | 2025/08/09 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 镥[177Lu]-BL-ARC001注射液 · No verified English name | CXSL2500631 | New drug | 2025/07/28 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500332 | New drug | 2025/04/28 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500144 | New drug | 2025/02/13 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500120 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500119 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500118 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500117 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500116 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500115 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2500114 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M11D1 · No verified English name | CXSL2500105 | New drug | 2025/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M09D1 · No verified English name | CXSL2500103 | New drug | 2025/02/07 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSB2500004 | Supplement | 2025/01/07 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M07D1 · No verified English name | CXSL2400836 | New drug | 2024/12/07 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400834 | New drug | 2024/12/07 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M07D1 · No verified English name | CXSL2400792 | New drug | 2024/11/23 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| GNC-038四特异性抗体注射液 · No verified English name | CXSL2400694 | New drug | 2024/10/15 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| GNC-038四特异性抗体注射液 · No verified English name | CXSL2400693 | New drug | 2024/10/15 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M08D1 · No verified English name | CXSL2400613 | New drug | 2024/09/13 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSB2400086 | Supplement | 2024/08/17 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| GNC-077多特异性抗体注射液 · No verified English name | CXSL2400460 | New drug | 2024/07/17 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M14D1 · No verified English name | CXSL2400291 | New drug | 2024/05/09 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M17D1 · No verified English name | CXSL2400237 | New drug | 2024/04/17 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M07D1 · No verified English name | CXSB2400033 | Supplement | 2024/04/13 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400183 | New drug | 2024/03/14 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B16D1 · No verified English name | CXSL2400159 | New drug | 2024/02/27 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400148 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400147 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400146 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400145 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400144 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400143 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400141 | New drug | 2024/02/22 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2400112 | New drug | 2024/02/08 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M07D1 · No verified English name | CXSL2400046 | New drug | 2024/01/20 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M07D1 · No verified English name | CXSL2400045 | New drug | 2024/01/20 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M05D1 · No verified English name | CXSL2300904 | New drug | 2023/12/28 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2300832 | New drug | 2023/12/01 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2300136 | New drug | 2023/02/16 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M11D1 · No verified English name | CXSL2300119 | New drug | 2023/02/11 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-B01D1 · No verified English name | CXSL2300029 | New drug | 2023/01/11 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| SI-B003双特异性抗体注射液 · No verified English name | CXSL2300028 | New drug | 2023/01/11 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用BL-M07D1 · No verified English name | CXSL2200209 | New drug | 2022/05/10 | Chengdu Bai Li Duo Te Bio Pharma Co., Ltd. romanized; Sichuan Baili Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.